November 2019

FDA ACCEPTS YUTIQ FOR PERSISTENT NONINFECTIOUS UVEITIS

Yutiq, a non-bioerodible intravitreal micro-insert having 0.18 mg fluocinolone acetonide, got FDA authorization for the therapy of chronic non-infectious uveitis affecting the posterior sector of the eye. In this context, Nancy Lurker, president and CEO of EyePoint Pharmaceuticals, said that “We are very grateful to the FDA for giving an early approval to Yutiq, which now… Read More »FDA ACCEPTS YUTIQ FOR PERSISTENT NONINFECTIOUS UVEITIS